Leadership Team Scientific Advisory Board Board of Directors

Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing

Notes from the Inside Viral Vector Science Videos + Webinars Articles

In the News Press Releases Conferences

Careers

Team ViroCell Leadership Team Scientific Advisory Board Board of Directors What we do Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing Innovative thinking Notes from the Inside Viral Vector Science Videos + Webinars Articles

News In the News Press Releases Conferences Manufacturing dreams Careers Contact Us

Articles

*In vivo* gene delivery: Why lentiviral vectors are a compelling alternative to AAV

April 2026

Learn more

*In vivo* gene delivery: The case for lentiviral vectors

September 2025

Build backwards: A new framework for rare disease gene therapy development

July 2025

De-risking cell and gene therapies by leveraging a proven workhorse technology in new ways

July 2025

Videos

Next-gen vectors: advancing in vivo and ex vivo gene delivery through intelligent design

watch

If you’re looking for a lentiviral and retroviral vector CDMO, we’d love to connect

Get in touch

videos Newsroom Careers Contact Us Terms of Use Privacy Notice

London

ViroCell Holdings Limited (trading as ViroCell Biologics), registered in England and Wales, Company No. 16812976. Registered Office: 5 New Street Square, London EC4A 3TW ©2026 ViroCell Holdings Limited. All rights reserved.